Chrysos Valuation

Is C79 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of C79 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate C79's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate C79's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for C79?

Key metric: As C79 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for C79. This is calculated by dividing C79's market cap by their current revenue.
What is C79's PS Ratio?
PS Ratio	12.6x
Sales	AU$45.36m
Market Cap	AU$573.47m

C79 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	11.4x
Enterprise Value/EBITDA	60.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does C79's PS Ratio compare to its peers?

The above table shows the PS ratio for C79 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.6x
KPG Kelly Partners Group Holdings	3.8x	n/a	AU$412.6m
IPH IPH	2.3x	5.2%	AU$1.4b
CUP Count	1.2x	16.9%	AU$134.7m
RTH RAS Technology Holdings	3.2x	n/a	AU$51.3m
C79 Chrysos	12.6x	28.4%	AU$573.5m

Price-To-Sales vs Peers: C79 is expensive based on its Price-To-Sales Ratio (12.6x) compared to the peer average (2.6x).

Price to Sales Ratio vs Industry

How does C79's PS Ratio compare vs other companies in the AU Professional Services Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
PPE Peoplein	0.07x	3.4%	US$55.36m
ASH Ashley Services Group	0.05x	n/a	US$17.78m
VRS Veris	0.2x	3.5%	US$14.56m
HMI Hiremii	0.3x	n/a	US$5.49m

7 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: C79 is expensive based on its Price-To-Sales Ratio (12.6x) compared to the Australian Professional Services industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is C79's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

C79 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	12.6x
Fair PS Ratio	6.3x

Price-To-Sales vs Fair Ratio: C79 is expensive based on its Price-To-Sales Ratio (12.6x) compared to the estimated Fair Price-To-Sales Ratio (6.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst C79 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	AU$4.98	AU$6.39 +28.2%	10.1%	AU$7.20	AU$5.50	n/a	4
Nov ’25	AU$5.34	AU$6.39 +19.6%	10.1%	AU$7.20	AU$5.50	n/a	4
Oct ’25	AU$5.62	AU$6.44 +14.5%	9.0%	AU$7.20	AU$5.70	n/a	4
Sep ’25	AU$5.98	AU$6.44 +7.6%	9.0%	AU$7.20	AU$5.70	n/a	4
Aug ’25	AU$5.07	AU$6.34 +25.0%	8.9%	AU$7.20	AU$5.70	n/a	4
Jul ’25	AU$5.41	AU$7.48 +38.2%	1.8%	AU$7.60	AU$7.25	n/a	4
Jun ’25	AU$5.54	AU$7.48 +34.9%	1.8%	AU$7.60	AU$7.25	n/a	4
May ’25	AU$5.51	AU$7.48 +35.7%	1.8%	AU$7.60	AU$7.25	n/a	4
Apr ’25	AU$6.93	AU$8.02 +15.7%	3.1%	AU$8.30	AU$7.70	n/a	3
Mar ’25	AU$7.04	AU$8.02 +13.9%	3.1%	AU$8.30	AU$7.70	n/a	3
Feb ’25	AU$6.63	AU$8.00 +20.7%	3.1%	AU$8.30	AU$7.70	n/a	3
Jan ’25	AU$8.10	AU$8.23 +1.6%	4.5%	AU$8.70	AU$7.80	n/a	3
Dec ’24	AU$7.81	AU$8.23 +5.4%	4.5%	AU$8.70	AU$7.80	n/a	3
Nov ’24	AU$7.06	AU$6.63 -6.2%	13.2%	AU$7.50	AU$5.75	AU$5.34	2
Oct ’24	AU$6.32	AU$6.48 +2.5%	6.6%	AU$6.90	AU$6.05	AU$5.62	2
Sep ’24	AU$6.09	AU$6.48 +6.3%	6.6%	AU$6.90	AU$6.05	AU$5.98	2
Aug ’24	AU$4.90	AU$5.80 +18.4%	1.7%	AU$5.90	AU$5.70	AU$5.07	2
Jul ’24	AU$5.09	AU$5.98 +17.4%	4.6%	AU$6.25	AU$5.70	AU$5.41	2
Jun ’24	AU$4.54	AU$5.98 +31.6%	4.6%	AU$6.25	AU$5.70	AU$5.54	2
May ’24	AU$4.10	AU$5.98 +45.7%	4.6%	AU$6.25	AU$5.70	AU$5.51	2
Apr ’24	AU$4.51	AU$5.98 +32.5%	4.6%	AU$6.25	AU$5.70	AU$6.93	2
Mar ’24	AU$3.69	AU$5.83 +57.9%	7.3%	AU$6.25	AU$5.40	AU$7.04	2
Feb ’24	AU$4.28	AU$6.35 +48.4%	15.0%	AU$7.30	AU$5.40	AU$6.63	2
Jan ’24	AU$2.91	AU$6.35 +118.2%	15.0%	AU$7.30	AU$5.40	AU$8.10	2

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.